<!doctype html>
<html lang="en"><head>
<meta charset="utf-8"/><meta name="viewport" content="width=device-width,initial-scale=1"/>
<link rel="stylesheet" href="/newsletter/style.css"/>
<title>1 Stock That Should Be in Every Investor&#x27;s Portfolio — Newsletter</title>
</head><body>
<div class="container">
  <div class="header">
    <h1 style="margin:0;font-size:28px">Newsletter</h1>
    <a class="btn" href="/newsletter/">Home</a>
  </div>
  <div class="card">
    <h2 style="margin-top:0">1 Stock That Should Be in Every Investor&#x27;s Portfolio</h2>
    <div class="badge">2025-09-15T10:15:00+00:00</div>
    <ul>
      <li>Q2 revenue gained 38% year over year to $15.56 billion.</li>
<li>alone, revenue increased 37% to $3.3 billion.</li>
<li>In fiscal 2023 and 2024, revenue increased 19.5% and 32% respectively.</li>
<li>Total worldwide sales increased 12% in the second quarter to $1.49 billion.</li>
<li>Looking forward, guidance is calling for 2025 earnings per share of $20.85 to $22.10.</li>
<li>The primary area of growth for this drug was outside the U.S., where revenue grew 19% to $560.3 million year over year.</li>
<li>Between fiscal 2023 and 2024, net income nearly doubled to $10.6 billion.</li>
    </ul>
    <p>
      <a class="btn" href="https://twitter.com/intent/tweet?text=1 Stock That Should Be in Every Investor&amp;#x27;s Portfolio\n• Q2 revenue gained 38% year over year to $15.56 billion.\n• alone, revenue increased 37% to $3.3 billion.\n• In fiscal 2023 and 2024, revenue increased 19.5% and 32% respectively.\n• Total worldwide sales increased 12% in the second quarter to $1.49 billion.\n• Looking forward, guidance is calling for 2025 earnings per share of $20.85 to $22.10.\n• The primary area of growth for this drug was outside the U.S., where revenue grew 19% to $560.3 million year over year.\n• Between fiscal 2023 and 2024, net income nearly doubled to $10.6 billion." target="_blank" rel="noopener">Tweet bullets</a>
      &nbsp;&nbsp;
      <a href="https://finance.yahoo.com/m/8fba6c14-66f5-3eb9-b5e8-8bf7429e2d86/1-stock-that-should-be-in.html" target="_blank" rel="noopener nofollow">finance.yahoo.com</a>
    </p>
  </div>
  <div class="footer">Built from digest_5bullets.md</div>
</div>
</body></html>